Remove 2003 Remove Doctors Remove Healthcare Remove Leads
article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

Self-stigma is also prevalent and hinders individuals from getting tested, starting pre‑exposure prophylaxis (PrEP) (if they’re HIV negative), seeking the lifesaving treatments they need (if they’re HIV positive), and can lead to isolation and depression. References 1. World Health Organization. The Global Health Observatory. Internet] 2023.

article thumbnail

How VMS BioMarketing Accelerated Digital Transformation with Silverline

Silver Line CRM

Reading time: 4 minutes A patient support network isn’t made up of just doctors or nurses. Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training. That’s Silverline.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. We’re in phase 1 of healthcare’s price transparency movement – internet data dump – but what’s next?

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Recorded Session from the 2022 Consumer Experience & Digital Health Forum The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. But first, let’s introduce the speakers!

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. The path to real zero.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

Can you share an update on the clinical trial for your lead candidate? He attended the College of the Holy Cross studying Mathematics and Physics and went on to receive his doctorate from the University of Arizona in Applied Mathematics under Professor Harrison H. Barrett at the Center for Gamma Ray Imaging.